newratings.com  May 18  Comment 
LONDON (dpa-AFX) - Aratana Therapeutics Inc.'s (PETX) Entyce has been approved by the FDA's Center for Veterinary Medicine for appetite stimulation in dogs. The company intends to commercially launch the product in conjunction with the...
newratings.com  Apr 1  Comment 
NEW YORK CITY (dpa-AFX) - BioTelemetry Inc. (BEAT) has reported revenue of $48.6 million for the first quarter ended March 31, 2016, which is the highest quarterly revenue in the company's history, and a 12% increase over prior year. The...
newratings.com  Feb 18  Comment 
WASHINGTON (dpa-AFX) - Aratana Therapeutics Inc. (PETX) has filed a Marketing Authorization Application with the European Medicines Agency for Galliprant, intended to treat pain and inflammation in dogs with osteoarthritis. The EMA has started...
Benzinga  Feb 17  Comment 
Shares of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) lost nearly half of its value Wednesday morning after the company disclosed it received a "Refusal to File" letter from the U.S. Food and Drug Administration. The "Refusal to File" letter...
newratings.com  Dec 17  Comment 
WASHINGTON (dpa-AFX) - Shares of Acasti Pharma Inc. (ACST) surged more than 56% on Wednesday on encouraging response from the FDA for the proposed 505(b)(2) pathway for CaPre clinical development. Last September, the company reported successful...
Motley Fool  Apr 24  Comment 
Catalyst Pharmaceutical Partners' shareholders discover that two's a crowd.

You may also be interested in articles related to Catalyst Pharmaceutical Partners (CPRX):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki